HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic factors in the palliation of pancreatic cancer.

AbstractAIM:
Few patients with pancreatic cancer are eligible for resection. In the remainder, estimation of prognosis is important to optimise various aspects of care, including palliation of biliary obstruction and trial of chemotherapy. The aim is to evaluate the prognostic significance of clinical and laboratory variables in patients with unresectable pancreatic cancer.
METHODS:
Information was gathered retrospectively for 325 patients with unresectable pancreatic cancer who underwent palliative interventions, including surgical bypass, endoscopic or percutaneous stenting or who received supportive care only.
RESULTS:
Histological proof was obtained in 182 patients (56%). Median survival was 5.7 months. Absence of therapeutic intervention, leukocytosis (WCC> or =11 x 10(9)/l), gamma glutamyl transferase (gamma GT)>165U/L, prothrombin time ratio > or =1.1, and C-reactive protein (CRP) > or = 5mg/dL were associated with shorter survival on univariate analysis. Only absence of therapeutic intervention, leukocytosis, and gamma GT>165 U/L reached significance on multivariate analysis. In the 51 patients in whom serum CRP was available, CRP was the only significant predictor of survival on multivariate analysis.
CONCLUSIONS:
Leukocytosis, elevated gamma GT and raised CRP predict shorter survival and may help to guide the choice of palliative intervention for patients with unresectable pancreatic cancer.
AuthorsF J F Engelken, V Bettschart, M Q Rahman, R W Parks, O J Garden
JournalEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (Eur J Surg Oncol) Vol. 29 Issue 4 Pg. 368-73 (May 2003) ISSN: 0748-7983 [Print] England
PMID12711291 (Publication Type: Journal Article)
Chemical References
  • C-Reactive Protein
  • gamma-Glutamyltransferase
Topics
  • Aged
  • C-Reactive Protein (metabolism)
  • Female
  • Humans
  • Leukocytosis (etiology)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Palliative Care
  • Pancreatic Neoplasms (enzymology, pathology, therapy)
  • Predictive Value of Tests
  • Prognosis
  • Prothrombin Time
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis
  • gamma-Glutamyltransferase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: